VR Logo

Auro Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1989

Chairman: Sharat Deorah

Managing Director: Sharat Deorah

Group: --

Listing: BSE: 530233

Headquarters: Thane, Maharashtra

Website: www.aurolabs.com

Key Facts

Market cap: R 24.62 Cr

Revenue (TTM): R 45.89 Cr

Earnings (TTM): R 5.17 Cr

Cash: R 4.11 Cr

Total Debt: R 8.09 Cr

Promoters' ownership: 51.92%

Liquidity: Moderate

52 Week range: R 23.00 - 64.90

Face value: R10.00

Shares outstanding: 62,32,500

10 Years Aggregate:

  • CFO: 30.88 Cr
  • EBITDA: 33.64 Cr
  • Net Profit: 12.32 Cr

Stock Performance

Time Period Auro Laboratories S&P BSE Healthcare S&P BSE Small Cap
YTD-17.0220.33-13.46
1 month-1.746.8711.32
3 months9.4214.23-12.77
1 Year-31.9321.43-20.39
3 Years-16.305.22-8.36
5 Years32.930.311.78
10 Years24.4011.353.21
As on 05-Jun-2020
Year Auro Laboratories S&P BSE Small Cap S&P BSE Healthcare
2019-15.75-6.85-3.55
2018-25.37-23.41-5.89
2017122.1159.640.49
201634.141.77-12.88
2015232.886.7615.06
20143.7169.2447.43
2013-47.80-11.2322.55